ArticleAtencion primaria
[Adherence of Type 2 Diabetes Mellitus approach: Current situation and possible solutions].
Article in Atencion primaria. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT04841096. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Safety of the Oral Combined Therapy Glimepiride / Vildagliptin / Metformin in Patients With Type 2 Diabetes With Dual Treatment Failure
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Cardiovascular preventive recommendations. PAPPS 2024 thematic updates].Atencion primaria · 2024Guideline
- Beyond Compliance: The Role of Self-Efficacy in Foot Care and Self-Management Among Patients With Type 1 Diabetes.TheScientificWorldJournal · 2025Trial
- Understanding the Roles of over 65-Year-Old Male and Female Carers: A Comparative Analysis of Informal Caregiving.Geriatrics (Basel, Switzerland) · 2025Article
- Article
- Safe Care and Medication Intake Provided by Caregivers at Home: Reality Care Study Protocol.Healthcare (Basel, Switzerland) · 2023Article
- Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus.Journal of personalized medicine · 2023Article
- [Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].Atencion primaria · 2022Article
- Psychometric properties of a questionnaire to measure adherence to treatment in patients with type 1 diabetes mellitus.Nursing open · 2022Article
- [Treatment adherence in a hospital emergency service].Revista espanola de salud publica · 2019Observational
- [Management of hyperglycaemia with non-insulin drugs in adult patients with type 2 diabetes].Atencion primariaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesDefine the impact and causes of non-adherent type-2 diabetes mellitus (DM2) patients, possible solutions and the role of the different health care professionals involved in the treatment.
designStructured questionnaire rating by a two-round Delphi method. LOCATION: The study was conducted in the Primary Care settings.
participantsThe expert panel consisted of renowned medical professionals with extensive experience in diabetes. MAIN MEASUREMENTS: Assessment through a 9-point Likert scale, of the degree of agreement or disagreement on 131 items grouped into 4 blocks: impact; causes of nonadherence; diagnosis of non-adherence, and possible causes, solutions and role of the different professionals involved in adherence.
resultsThe participation rate was 76.31%. The primary care health professionals agreed on 110 of the 131 proposals statements (84%), showing agreement on 102 items (77.9%) and disagreement in 8 (6.1%). Consensus was not reached on 21 items.
conclusionsThe lack of adherence of DM2 patients makes the achievement of therapeutic control difficult. The medical practice needs to have specific training and enough resources to reduce the impact of the lack of therapeutic compliance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.